Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Tool · Insurance · United States

Will insurance cover a GLP-1? A quick checker

Whether a GLP-1 medicine is covered depends on the kind of coverage you have. Pick yours below to see what applies and what to ask. This is general information, not advice about your plan, and a prescription is always decided by a licensed clinician.

Edited by Gabriel BrocklesbyFounder & EditorFact-checkedLast updated

What coverage do you have?

Nothing you choose here is saved or sent anywhere.

The Medicare GLP-1 Bridge, in plain words

  • A time-limited Medicare demonstration running from July 1, 2026 to December 31, 2027 (CMS).
  • Eligible people in a Medicare Part D plan pay a $50 copay for a monthly supply of certain GLP-1 medicines (CMS).
  • The Part D deductible does not apply, the copay does not count toward your true out-of-pocket costs, and no low-income subsidy is provided for it (CMS).
  • A central processor handles prior authorization, claims and payment to pharmacies (CMS).
  • The Bridge covers Foundayo (tablet), Wegovy (injection or tablet) and the Zepbound KwikPen only, not Zepbound vials, at $50 a month from July 1, 2026 to December 31, 2027 for those who qualify. Source: Medicare.gov fact sheet: Medicare GLP-1 Bridge (CMS Product No. 12234) (June 2026; read October 30, 2026). The National Council on Aging reports eligibility as a BMI of 35 or higher; or 30 or higher with heart failure, uncontrolled hypertension or kidney disease; or 27 or higher with a previous stroke, prediabetes, a previous heart attack or peripheral artery disease.
  • Check eligibility at Medicare.gov/glp1bridge, or call 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048).

Read on CMS's and NCOA's pages on October 17, 2026.

For the rules drug by drug, see does Medicare cover Zepbound?, does Medicare cover Wegovy? and does Medicare cover Ozempic?

Questions to ask your insurer

  1. Does my plan cover GLP-1 medicines for weight management, or only for type 2 diabetes?
  2. Which medicines are on the formulary, and at what tier and copay?
  3. Is prior authorization needed, and what does my prescriber have to document?
  4. Do I have to try another treatment first (step therapy)?
  5. Are there quantity limits or a maximum length of coverage?
  6. Does a telehealth prescriber count, or must it be an in-network clinician?

If you have Medicaid, see Medicaid GLP-1 coverage by state for what your state covers, with its criteria and sources.

For Zepbound in particular, see does Medicaid cover Zepbound?

GLP-1 weight loss coverage by insurer and PBM

What each insurer's or pharmacy benefit manager's (PBM's) own public policy says about Wegovy and Zepbound for weight management, checked November 1, 2026. UnitedHealthcare, Cigna and CVS Caremark say coverage depends on what the employer chose; the policy then sets the criteria. Always confirm with your plan.

Insurer or PBMWhat its public policy saysPrior authorizationDoes it depend on your plan?Source
Aetna2026 Wegovy policy: adults with a BMI of 30 or more, or 27 or more with a weight-related condition (for example high blood pressure, type 2 diabetes or high cholesterol), after at least 6 months in a weight management programme. Renewal needs at least 5 percent of baseline weight lost, or kept off, after 3 months on a stable dose. A second 2026 policy (Wegovy, Zepbound, Foundayo) requires a BMI of 35 or more.Yes, with documentation.The policies set criteria only. Whether your plan covers weight-loss medicines, and which policy it uses: ask your plan.Aetna 4774-C; Aetna 6450-C. Checked November 1, 2026.
Cigna (Evernorth, Express Scripts)Zepbound weight-loss policy: a trial of behavior change and diet, a minimum BMI and, at the lower BMI, a weight-related condition such as high blood pressure, type 2 diabetes or sleep apnoea. Approved for 8 months, then a year at a time. Cigna lists separate Wegovy and Zepbound policies at BMI 30, 32 and 35. Express Scripts added both to its Patient Assurance Program for participating plans and employers (July 10, 2025).Yes.Yes. Cigna says your benefit plan document comes first and may exclude the medicine.Cigna IP 0816; Cigna policy index; Evernorth, July 10, 2025. Checked November 1, 2026.
UnitedHealthcare (Optum Rx)2026 commercial weight-loss program (Wegovy, Zepbound, Foundayo and others): used with lifestyle changes, plus a BMI threshold or a lower BMI with a weight-related condition. Approvals last 5 months for Wegovy and 6 for Zepbound. Some fully insured plans in California, New Mexico, New York and North Dakota follow a separate program. No separate public Optum Rx policy found for other plans.Yes.Yes. UnitedHealthcare calls it "an optional program" for businesses that elect to cover weight loss products.UnitedHealthcare 2026 P 1114-23; UnitedHealthcare requirements list. Checked November 1, 2026.
CVS CaremarkAnnounced May 28, 2026: Zepbound returns to its commercial formularies as an additional preferred option from October 1, 2026, and Foundayo's new-to-market block ended on June 1, 2026 where plans approve it. Lilly's coverage page says some employers reinstated Zepbound earlier.Not stated: ask your plan.Yes. It applies to plan sponsors who elect to cover these medicines, and sponsors can customize coverage.CVS Health, May 28, 2026; Lilly. Checked November 1, 2026.
Blue Cross Blue ShieldBlue plans differ by state and employer; there is no single policy. Example, FEP Blue (federal employees) Zepbound policy from January 1, 2026: a minimum BMI, or 27 or more with heart disease or a weight-related condition; at least two oral weight-management medicines tried first unless unsuitable; a weight management programme; and the preferred product first.Yes for FEP Blue. Other Blue plans: ask your plan.Other Blue plans: no single public policy found; ask your plan.FEP Blue 5.99.031. Checked November 1, 2026.
Kaiser PermanenteNorthwest region: Zepbound is non-formulary and needs a clinical review. Criteria include a BMI of 30 or more, or 27 or more with high blood pressure, diabetes or high cholesterol, a diet and exercise program, and a 3-month trial of at least two other weight-loss medicines unless unsuitable. Members without a weight-loss benefit "pay member cash price".Yes (clinical review), Northwest region.Yes: only members whose benefit covers weight-loss medicines. Other regions: no public policy found; ask your plan.Kaiser Permanente Northwest. Checked November 1, 2026.

Insurer or PBM not listed? Ask your plan. For Medicare, see the Bridge section above; for Medicaid, see Medicaid GLP-1 coverage by state.

Prior authorization and appeals, step by step

Every insurer policy in the table asks for prior authorization or a clinical review. Appeal rights below are from HealthCare.gov and federal rules; criteria are from the insurers' policies, read November 1, 2026.

  1. Check your drug list and your benefit

    In your member portal or on the number on your card, ask two things: is the medicine on the formulary (the plan's drug list), and does the plan cover weight-loss medicines at all? Several insurers leave the second to the employer. NovoCare and Lilly run coverage checkers too, though Lilly says its result is not a guarantee.

    Source: Lilly; UnitedHealthcare 2026 P 1114-23.

  2. Ask for the prior authorization criteria

    Ask which clinical policy your plan uses. Criteria differ even within one insurer: Aetna has policies at BMI 30 and 35, Cigna at 30, 32 and 35.

    Source: Aetna 6450-C; Cigna policy index.

  3. Your prescriber submits the evidence

    Commonly: the diagnosis, a recent weight and BMI, any weight-related conditions, and a record of a diet, exercise or behavior program (Aetna asks for 6 months). FEP Blue and Kaiser Permanente Northwest also ask about at least two weight-management medicines tried before. Lilly publishes a prior authorization guide and a sample letter of medical necessity; NovoCare offers prescribers a case manager for prior authorization and appeals.

    Source: Aetna 4774-C; FEP Blue 5.99.031; Kaiser Permanente Northwest; Lilly; NovoCare.

  4. Ask for an exception if it is not on the list

    A formulary exception asks the plan to cover a drug that is not on its list. Plans that must cover essential health benefits, such as Marketplace plans, must decide within 72 hours, or 24 hours when your health is at serious risk or you are already taking the drug. Employer plans may differ: ask.

    Source: 45 CFR 156.122.

  5. Know the timeline, and the renewal date

    The insurer must answer in writing, with reasons, within 15 days for prior authorization, or 72 hours for urgent care. Approvals expire (5 to 8 months at UnitedHealthcare and Cigna), and renewal can depend on results, so note the date.

    Source: HealthCare.gov, internal appeals; UnitedHealthcare 2026 P 1114-23; Cigna IP 0816.

  6. File an internal appeal within 180 days

    Use the plan's form, or write with your name, claim number and insurance ID, and add a letter from your prescriber; Lilly notes many plans want a letter of medical necessity. Keep copies and notes of every call. The plan must decide within 30 days, and your state's Consumer Assistance Program can file for you.

    Source: HealthCare.gov, internal appeals; Lilly.

  7. Ask for an external review

    If the appeal fails, ask in writing within 4 months for an independent review; the insurer must accept the decision. Standard reviews take up to 45 days, urgent ones up to 72 hours, and in an urgent case you can file it alongside the internal appeal.

    Source: HealthCare.gov, external review; HealthCare.gov, internal appeals.

  8. Meanwhile, savings and cash

    Both manufacturers' copay offers are for commercial insurance; Lilly's card excludes government programs, and NovoCare offers those patients its self-pay price. Lilly's self-pay Zepbound vials and KwikPen through LillyDirect need no prior authorization. See the cost guides below for prices.

    Source: NovoCare savings offer; Lilly savings card terms; Lilly.

Cash prices, read daily: Wegovy cost without insurance, Zepbound cost without insurance and the US GLP-1 price index.

If insurance will not cover it

Most online GLP-1 programs are cash-pay. The US GLP-1 price index lists every price we track, read daily from each provider's own page, with 3, 6 and 12 month costs. For a ranking, see the cheapest GLP-1 online or the best online GLP-1 programs by use case. If it is tirzepatide you would be paying for, see what compounded tirzepatide costs per month. Compounded medicines are not FDA approved.

If it is Wegovy, see what Wegovy costs without insurance, from the manufacturer's self-pay price to telehealth programs, read daily.

Frequently asked questions

Does Medicare cover GLP-1 medicines for weight loss?

From July 1, 2026 to December 31, 2027, the Medicare GLP-1 Bridge lets eligible people in a Medicare Part D plan get a monthly supply of certain GLP-1 medicines for a $50 copay. It is a time-limited demonstration, eligibility depends on weight and health conditions, and a prior authorization is needed. Check at Medicare.gov/glp1bridge or call 1-800-MEDICARE.

Which medicines are in the Medicare GLP-1 Bridge?

The Bridge covers Foundayo (tablet), Wegovy (injection or tablet) and the Zepbound KwikPen only, not Zepbound vials, at $50 a month from July 1, 2026 to December 31, 2027 for those who qualify. Source: Medicare.gov fact sheet: Medicare GLP-1 Bridge (CMS Product No. 12234), June 2026, read October 30, 2026.

Does the $50 copay count toward my Part D out-of-pocket costs?

No. CMS says the Part D deductible does not apply, the $50 copay does not count toward your true out-of-pocket costs, and no low-income subsidy is provided for it.

Does insurance cover compounded semaglutide or tirzepatide?

Generally plan by plan, and most online programs selling compounded GLP-1 medicines are cash-pay. Compounded medicines are not FDA approved. Ask your plan directly if you hope to claim.

Does this checker collect my information?

No. Your answer stays in your browser and is not saved or sent anywhere.

How do I find out if my insurance covers GLP-1s?

Call the number on your insurance card or check your plan's drug list (formulary). Ask whether weight-loss medicines are covered at all, which are listed, and whether prior authorization is needed. UnitedHealthcare, Cigna and CVS Caremark say this depends on the employer's choice, so two people with the same insurer can get different answers.

What is prior authorization for Wegovy or Zepbound?

Your insurer's approval before it pays. Your prescriber sends evidence that you meet the plan's criteria, commonly BMI, weight-related conditions and a diet, exercise or behavior program. Approvals are time-limited. HealthCare.gov says the insurer must decide in writing within 15 days, or 72 hours for urgent care.

What can I do if my insurer denies coverage?

File an internal appeal within 180 days of the denial, with a letter of medical necessity from your prescriber. If the plan still says no, ask for an independent external review within 4 months; the insurer must accept its decision. Your state's Consumer Assistance Program can help (HealthCare.gov).

Sources